View More
In patients with HFpEF, sacubitril/valsartan attenuated the rate of decline in renal outcomes similarly in patients with and without diabetes compared to valsartan alone.
In ambulatory patients with heart failure, low-sodium diet showed a modest quality-of-life benefit and improvement in NYHA class, but no improvement in all-cause mortality or CV-related hospitalizations.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.